Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

"Dietary antioxidant" definition based on in vivo activity proposed by FNB panel.

This article was originally published in The Tan Sheet

Executive Summary

"DIETARY ANTIOXIDANT" DEFINITION DEPENDENT ON IN VIVO ACTIVITY in humans is proposed in a report issued July 21 by the Food & Nutrition Board's Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and the committee's Panel on Dietary Antioxidants and Related Compounds. The definition of "antioxidant" proposed in the report is based on several criteria. First, the substance must be one that is "found in human diets"; second, the "content of the substance" has to have been "measured in foods commonly consumed"; and third, in humans, the substance must decrease "the adverse effects of reactive oxygen and nitrogen species in vivo," the report states. FNB is a division of the Institute of Medicine.

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel